Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man
- 1 October 1993
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 38 (10) , 1889-1892
- https://doi.org/10.1007/bf01296114
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumideAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1991
- Cholecystokinin is not a major hormonal regulator of lower esophageal sphincter pressureGastroenterology, 1990
- Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in manEuropean Journal of Clinical Pharmacology, 1990
- Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.Journal of Clinical Investigation, 1990
- ROLE OF CHOLECYSTOKININ IN REGULATION OF GASTROINTESTINAL MOTOR FUNCTIONSThe Lancet, 1989
- Effect of cholestyramine on plasma cholecystokinin and pancreatic polypeptide levels, and exocrine pancreatic secretionEuropean Journal of Clinical Investigation, 1988
- Regulation of the release of cholecystokinin by bile salts in dogs and humansGastroenterology, 1988
- Effect of The C-Terminal Octapeptide of Cholecystokinin on Lower Esophageal Sphincter Pressure in ManGastroenterology, 1973
- Inhibition of the lower oesophageal sphincter by fat a mechanism for fatty food intoleranceGut, 1973
- Quantification of the Binding Tendencies of Cholestyramine I: Effect of Structure and Added Electrolytes on the Binding of Unconjugated and Conjugated Bile-Salt AnionsJournal of Pharmaceutical Sciences, 1969